Corteva, Inc. $CTVA Shares Sold by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. trimmed its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 22.2% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 410,143 shares of the company’s stock after selling 116,891 shares during the quarter. Eurizon Capital SGR S.p.A.’s holdings in Corteva were worth $31,848,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. Parkside Financial Bank & Trust increased its stake in shares of Corteva by 3.2% in the second quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock worth $316,000 after acquiring an additional 116 shares during the period. HB Wealth Management LLC raised its holdings in shares of Corteva by 0.5% during the second quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock worth $2,018,000 after purchasing an additional 128 shares during the last quarter. Wilkerson Advisory Group LLC lifted its position in Corteva by 6.7% during the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after purchasing an additional 133 shares during the period. Aviance Capital Partners LLC lifted its position in Corteva by 1.3% during the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after purchasing an additional 137 shares during the period. Finally, Pinnacle Wealth Management Advisory Group LLC boosted its holdings in Corteva by 3.2% in the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 4,762 shares of the company’s stock valued at $403,000 after purchasing an additional 147 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Trading Up 2.4%

Shares of Corteva stock opened at $9.41 on Friday. The firm has a 50-day simple moving average of $37.22 and a two-hundred day simple moving average of $69.57. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.10 and a current ratio of 1.56. Corteva, Inc. has a fifty-two week low of $9.01 and a fifty-two week high of $90.97. The company has a market cap of $6.28 billion, a P/E ratio of 4.96, a price-to-earnings-growth ratio of 1.72 and a beta of 0.58.

Corteva Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be paid a $0.05 dividend. The ex-dividend date is Tuesday, December 1st. This represents a $0.20 annualized dividend and a dividend yield of 2.1%. This is a drop from Corteva’s previous quarterly dividend of $0.18. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Corteva News Summary

These are some of the CTVA news items that stood out recently:

• Neutral Sentiment: Several analysts lowered price targets following the outlook reset. Citigroup and UBS kept neutral ratings, while JPMorgan maintained overweight and RBC kept outperform ratings, signaling some analysts still see potential upside from recent levels. Read More. · Read More. · Read More. · Read More.
• Negative Sentiment: The earnings miss and lowered full-year outlook are the key near-term headwinds, with Brazil weakness and competitive pricing hurting results. Reuters report on Brazil weakness and forecast cut
• Negative Sentiment: Law firms announced investigations into potential securities-law violations related to company disclosures. These are allegations under investigation, not findings of wrongdoing, but may add uncertainty for investors. Law firm investigation announcement

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Citigroup cut their price target on Corteva from $13.65 to $10.30 and set a “neutral” rating on the stock in a research report on Friday. Deutsche Bank reissued a “buy” rating and issued a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. Royal Bank Of Canada lowered their target price on Corteva from $17.00 to $11.00 and set an “outperform” rating on the stock in a research note on Friday. Bank of America raised their target price on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Finally, Zacks Research cut Corteva from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 6th. Fifteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $52.60.

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.